Pruritus response and skin biomarkers of atopic dermatitis with crisaborole vs. vehicle in patients with mild-to-moderate atopic dermatitis

被引：0
|
作者：
Bissonnette, R. [1 ]
Guttman-Yassky, E. [2 ]
Werth, J. L. [3 ]
Zang, C. [3 ]
Cha, A. [4 ]
Vlahos, B. [3 ]
Myers, D. E. [3 ]
Nocka, K. H. [5 ]
Ports, W. C. [6 ]
机构：
[1] Innovaderm Res, Montreal, PQ, Canada
[2] Icahn Sch Med Mt Sinai, Lab Inflammatory Skin Dis, New York, NY 10029 USA
[3] Pfizer Inc, Collegeville, PA USA
[4] Pfizer Inc, New York, NY USA
[5] Pfizer Inc, Cambridge, MA USA
[6] Pfizer Inc, Groton, CT 06340 USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2020年 / 183卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P20
引用
收藏
页码：E104 / E104
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of crisaborole in patients with mild-to-moderate atopic dermatitis and other atopic comorbidities
    Spergel, Jonathan M.
    Blaiss, Michael S.
    Lio, Peter
    Kessel, Aharon
    Cantrell, Wendy C.
    Takiya, Liza
    Werth, John L.
    O'Connell, Michael A.
    Zang, Chuanbo
    Cork, Michael J.
    ALLERGY AND ASTHMA PROCEEDINGS, 2021, 42 (05) : 425 - 431
  • [2] Impact of Crisaborole on Sleep Outcomes in Pediatric Patients with Mild-to-Moderate Atopic Dermatitis
    Fowler, Joseph
    Sugarman, Jeffrey
    Sher, Lawrence
    Zang, Chuanbo
    Werth, John L.
    Myers, Daniela E.
    Graham, Daniela
    Marfo, Alexander Agyei
    Takiya, Liza
    DERMATOLOGY AND THERAPY, 2023, 13 (04) : 951 - 960
  • [3] EFFICACY OF CRISABOROLE IN PATIENTS WITH MILD-TO-MODERATE ATOPIC DERMATITIS WITH AND WITHOUT FOOD ALLERGIES
    Blaiss, M.
    Cork, M.
    Lio, P.
    Kessel, A.
    Takiya, L.
    Werth, J.
    O'Connell, M.
    Zang, C.
    Spergel, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S40 - S41
  • [4] Crisaborole in patients ≥3 months of age with mild-to-moderate atopic dermatitis (AD)
    Su, J. C.
    Spelman, L. J.
    Eichenfield, L. F.
    Gold, L. F. Stein
    Cha, A.
    Graham, D.
    Takiya, L.
    Werth, J. L.
    Zang, C.
    Vlahos, B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (07) : S70 - S70
  • [5] Impact of Crisaborole in Treatment-Experienced Patients With Mild-to-Moderate Atopic Dermatitis
    Gold, Linda F. Stein
    Tom, Wynnis L.
    Shi, Vivian
    Sanders, Paul
    Zang, Chuanbo
    Vlahos, Bonnie
    Cha, Amy
    DERMATITIS, 2024, 35 (01) : 84 - 91
  • [6] Impact of Crisaborole on Sleep Outcomes in Pediatric Patients with Mild-to-Moderate Atopic Dermatitis
    Joseph Fowler
    Jeffrey Sugarman
    Lawrence Sher
    Chuanbo Zang
    John L. Werth
    Daniela E. Myers
    Daniela Graham
    Alexander Agyei Marfo
    Liza Takiya
    Dermatology and Therapy, 2023, 13 : 951 - 960
  • [7] Improvement in Disease Severity and Pruritus Outcomes With Crisaborole Ointment, 2%, by Baseline Atopic Dermatitis Severity in Children and Adolescents With Mild-to-Moderate Atopic Dermatitis
    Eichenfield, L. F.
    Yosipovitch, G.
    Gold, Stein L. F.
    PEDIATRICS, 2021, 148 : S18 - S19
  • [8] Improvement in disease severity and pruritus outcomes with crisaborole ointment, 2%, by baseline atopic dermatitis severity in children and adolescents with mild-to-moderate atopic dermatitis
    Eichenfield, Lawrence F.
    Yosipovitch, Gil
    Stein Gold, Linda F.
    Kalabis, Mizuho
    Zang, Chuanbo
    Vlahos, Bonnie
    Sanders, Paul
    Myers, Daniela E.
    Bushmakin, Andrew G.
    Cappelleri, Joseph C.
    Olivadoti, Melissa
    Paller, Amy S.
    PEDIATRIC DERMATOLOGY, 2020, 37 (06) : 1030 - 1037
  • [9] 2% Crisaborole topical ointment for the treatment of mild-to-moderate atopic dermatitis
    Cheape, Alice C.
    Murrell, Dedee F.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (05) : 415 - 423
  • [10] Crisaborole (Eucrisa) for Mild to Moderate Atopic Dermatitis
    Castelli, Gregory
    Schaffer, Monica
    AMERICAN FAMILY PHYSICIAN, 2018, 98 (06) : 379 - 380
12345